Evidence map›Paper›PMID 34075199›Full record

Trial reportScientific reports2021

Reliability and efficacy of maximum fluorescein tear break-up time in diagnosing dry eye disease.

Yujie Mou, Huan Xiang, Lin Lin, Kelan Yuan, Xin Wang, Yaying Wu, Jinjin Min, Xiuming Jin

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Agreement Between Tear Film Tests Performed by Novice Examiners.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yujie MouEye Center, the Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Huan XiangEye Center, the Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Lin LinEye Center, the Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Kelan YuanEye Center, the Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Xin WangEye Center, the Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Yaying WuEye Center, the Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Jinjin MinEye Center, the Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Xiuming JinEye Center, the Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China. lzyjxm@zju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to investigate the reliability and efficacy of maximum fluorescein tear break-up time (FTBUTmax) in diagnosing dry eye disease (DED). 147 participants were enrolled in this study. Ocular symptoms were assessed by Ocular Surface Disease Index (OSDI). The fluorescein tear break-up time (FTBUT) examination, corneal fluorescein staining (CFS), and Schirmer I test were performed on both eyes. Each participant underwent 3 consecutive FTBUT tests, and five types of FTBUT values including FTBUTmax, the minimum FTBUT (FTBUTmin), the first FTBUT (FTBUT1), the average of three FTBUTs (FTBUT123) and the average of the first and second FTBUT (FTBUT12) were recorded. FTBUTmax was larger than the other FTBUT values, but no differences were found among the values of FTBUT1, FTBUT123, FTBUT12 and FTBUTmin. In the ROC analysis, FTBUTmax had the largest or the second largest area under the ROC (AUROC) in all three DED diagnostic criteria, while FTBUTmin had the least AUROC of them. ROC efficacy of FTBUTmax was significantly higher than that of FTBUT123, FTBUT12, FTBUT1 and FTBUTmin in the OSDI criteria and higher than that of FTBUT1 and FTBUTmin in Schirmer I test and CFS tests. FTBUTmax has a close correlation with OSDI, Schirmer I test and CFS, and is an effective tool for the DED diagnosis.

Indexed as

AdultDry Eye SyndromesFemaleFluoresceinHumansMaleMiddle AgedProspective StudiesTearsFluorescein

Identifiers

PMID34075199
PMCPMC8169885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.